不同细胞来源的TNF在关节炎中的相反作用
该研究利用条件性敲除小鼠在胶原诱导性关节炎(CIA)和胶原抗体诱导性关节炎模型中,鉴定保护性与致病性TNF的细胞来源及其分子形式。结果显示髓系细胞来源TNF促进关节炎诱导和发病,T细胞来源TNF在诱导期通过限制树突细胞白介素-12产生及自身反应性记忆T细胞发育而具保护作用,B细胞来源TNF通过控制致病性自身抗体产生介导CIA严重程度。结论提示选择性靶向髓系细胞TNF而保留其他细胞来源的保护性TNF可能优于泛anti-TNF治疗。
要点
- 髓系细胞来源TNF促进自身免疫性关节炎的诱导和发病。
- T细胞来源TNF在关节炎诱导期具保护作用,效应期非必需。
- B细胞来源TNF通过控制致病性自身抗体产生介导CIA严重程度。
核心结论
- 不同产生TNF的细胞类型可能通过不同机制调节疾病发展,选择性清除髓系细胞等受限来源的TNF而保留其他细胞类型的保护性TNF功能,可能优于泛anti-TNF治疗。
研究设计与样本
- 采用缺乏特定细胞类型(如髓系细胞和T或B淋巴细胞)TNF表达的小鼠,以及缺乏可溶性TNF产生的小鼠,进行胶原诱导性关节炎(CIA)和胶原抗体诱导性关节炎实验。
- 评估疾病严重程度和发病率以及体液和细胞免疫应答。
主要发现
- 髓系细胞来源TNF促进自身免疫性关节炎的诱导和发病。
- T细胞来源TNF在关节炎诱导期通过限制树突细胞产生白介素-12及后续控制自身反应性记忆T细胞发育而具保护作用,但在效应期非必需。
- B细胞来源TNF通过控制致病性自身抗体产生介导CIA的严重程度。
临床怎么用
- 提示在关节炎治疗中,选择性靶向髓系细胞来源TNF而保留其他细胞类型的保护性TNF功能,可能比泛anti-TNF治疗更优。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Neutralisation of tumour necrosis factor (TNF) is widely used as a therapy for rheumatoid arthritis (RA). However, this therapy is only effective in less than a half of patients and is associated with several side effects. We hypothesised that TNF may possess non-redundant protective and immunomodulatory functions in vivo that cannot be blocked without a cost. The present work aimed to identify cellular sources of protective and pathogenic TNF, and its molecular forms during autoimmune arthritis. METHODS: Mice lacking TNF expression by distinct cell types, such as myeloid cells and T or B lymphocytes, were subjected to collagen-induced arthritis (CIA) and collagen antibody-induced arthritis. Mice lacking soluble TNF production were also employed. The severity and incidence of the disease, as well as humoral and cellular responses were assessed. RESULTS: Myeloid cell-derived TNF contributes to both induction and pathogenesis of autoimmune arthritis. Conversely, T cell-derived TNF is protective during the induction phase of arthritis via limiting of interleukin-12 production by dendritic cells and by subsequent control of autoreactive memory T cell development, but is dispensable during the effector phase of arthritis. B cell-derived TNF mediates severity of CIA via control of pathogenic autoantibody production. CONCLUSIONS: Distinct TNF-producing cell types may modulate disease development through different mechanisms, suggesting that in arthritis TNF ablation from restricted cellular sources, such as myeloid cells, while preserving protective TNF functions from other cell types may be superior to pan-anti-TNF therapy.
引用
- Kruglov A, Drutskaya M, Schlienz D, et al. Contrasting contributions of TNF from distinct cellular sources in arthritis. Ann Rheum Dis. 2020. PMID: 32796044. doi:10.1136/annrheumdis-2019-216068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。